Herpes simplex virus (HSV) causes many disease states including mucosal lesions, encephalitis or disseminated infection in the immunocompromised host. These diverse clinical manifestations reflect the capacity of the virus to infect both epithelial and neuronal cell types. Determining the requirements for virus entry into both cell types may provide insights into the pathogenesis of HSV. Previous studies have focused on identifying viral and cellular requirements for entry using epithelial cells. However, little is known about the requirements for binding and entry into neuronal cells. The purpose of the studies reported here was to identify viral and cellular components involved in entry of HSV-1 into primary neuronal cells. Heparan sulfate glycosaminoglycans were found to serve as a receptor for entry of HSV-1 into primary neuronal cells. Evidence
Introduction
Herpes simplex virus (HSV) infects a wide range of cells and, in its normal life-cycle, mainly infects two distinct cell types, epithelial and neuronal cells (Roizman & Sears, 1993) . Following primary infection of mucosal epithelial cells, HSV attaches to nearby nerve cell termini of sensory nerve fibres of the peripheral nervous system (PNS). Under certain conditions, virus travels from the PNS to the central nervous system (CNS) by ascending retrograde axonal transport. In the PNS\CNS, HSV enters neuronal cells to establish either a productive or latent infection. Recent studies have focused primarily on understanding the viral factors that contribute to neuroinvasiveness (ability to reach the CNS), neurovirulence (ability to induce CNS disease) and latency (Fraser & Valyi-Nagy, 1993 ; Steiner & Kennedy, 1993) . Little information is available about the cellular or viral requirements for initial binding and entry of virus into neurons. Because of its propensity for being both neurovirulent and neuroinvasive and causing life-threatening CNS infections, elucidating the mechanism of HSV binding and entry into neurons is important.
Using permanent epithelial cells, it has been demonstrated that heparan sulfate (HS), a ubiquitous glycosaminoglycan (GAG) found in plasma membrane and basement membrane in many tissues, serves as a cell surface receptor (Bernfield et al., 1992 ; Hook et al., 1984 ; Lycke et al., 1991 ; Ripellino & Margolis, 1989 ; Shieh et al., 1992 ; WuDunn & Spear, 1989) . Evidence includes studies showing that virus does not bind to epithelial cell surfaces pretreated enzymatically with heparinase or heparitinase, nor to mutant cell lines that fail to synthesize HS (Shieh et al., 1992 ; WuDunn & Spear, 1989) . In addition, soluble heparin, which is structurally and chemically similar to HS (Lindahl & Kjellen, 1987) , and heparin binding proteins (e.g. platelet factor 4 and the polycation, neomycin) block the binding of virions to cells (Herold & Spear, 1994 ; WuDunn & Spear, 1989) . Heparin presumably occupies virion sites necessary for attachment to cell surface HS, whereas platelet factor 4 and neomycin bind to cell surface HS to which virions normally bind, presumably by competing with the virus for available receptor sites associated with the cell surface HS (Herold & Spear, 1994 ; WuDunn & Spear, 1989) . In addition, results obtained demonstrate that the initial step in virus binding to HS is mediated by HSV-1 glycoprotein C (gC) (and\or gB) (Campadelli-Fiume et al., 1990 ; Herold et al., 1991 Herold et al., , 1994 Shieh et al., 1992 ; Spear, 1993 ; Tal-Singer et al., 1995 ; Trybala et al., 1994) . The evidence is summarized by the following observations. For most HSV-1 strains tested, deletion of gC alone, but not gB alone, results in virions that are impaired in specific binding activity (Herold et al., 1991 ; Spear, 1993) . Deletion of both gC and gB abolishes virus binding (Herold et al., 1994) . Moreover, neutralizing antibodies specific for gC but not other viral glycoproteins, block binding of virus to cells (Fuller & Spear, 1985 ; Svennerholm et al., 1991) . Despite its importance in virus binding, virions devoid of gC are still infectious. Following the initial binding of gC (and\or gB) to epithelial cell surface HS, HSV-1 interacts with other cell surface receptors to mediate entry (Brunetti et al., 1994 ; Spear, 1993) . Studies suggest that subsequent interactions include binding of gD to a cell surface component(s), and participation of gB and hetero-oligomers of gH and gL to mediate virus penetration via fusion of the virion envelope with the cell plasma membrane. A recent study suggests that a human cDNA encoding a novel member of the TNF\NGF receptor family may mediate the entry of HSV into some cell types (Montgomery et al., 1996) .
It is not known whether the requirements for HSV entry may vary for epithelial and neuronal cells as has been postulated in the case of other viruses such as human immunodeficiency virus type 1 (HIV-1). It has been proposed that galactosylceramide or its derivative may play a role as a receptor for the binding of HIV-1 to neuronal cells, whereas the CD4 antigen is the receptor for the binding of virus to reticuloendothelial cells (Bhat et al., 1991 ; Parmantier et al., 1995 ; Peudenier et al., 1991) . Since proteoglycans are complex and structurally diverse, it is possible that for HSV either a different family of GAGs might mediate virus binding to neurons or the structural sequences within the GAG might differ for neuronal cells compared to epithelial cells. Not only might the cell surface receptor differ, but the relative contribution of individual viral envelope glycoproteins to virus entry might differ between neuronal and epithelial cells.
HSV infects many different neural cell types, including neurons, glial cells, astrocytes and also malignant neuronal cells, such as neuroblastoma cells (Chou & Roizman, 1992 ; Roizman & Sears, 1993) . Although HSV is isolated only in humans and chimpanzees under natural conditions, the virus has a broad host range under experimental conditions (Roizman & Sears, 1993) . For example, primary cultures of chick embryo retinal neurons and photoreceptors have been successfully used to study the susceptibility of various retinal cell types to HSV infection (Politi et al., 1987) . The chick embryo brain has several distinct advantages. Primary cultures undergo morphologic differentiation that include migration, extension of neurites, synaptoses with adjacent cells and aggregation. While GAGs have been demonstrated in brain from several different species (Morris et al., 1977 ; Oohira et al., 1986 a, b) , they have been well characterized in the chick embryo system (Burg et al., 1995 ; Cole et al., 1985 ; Hennig et al., , 1993 Krueger et al., 1992) . Therefore, using the embryonic chick brain as a model, the present studies were undertaken to begin to identify viral and cellular components that participate in entry of HSV-1 into primary neuronal cells.
Methods
Cell lines and viruses. HEp-2 and Vero cell lines were obtained from the ATCC. HEp-2 cells were passaged in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % foetal bovine serum. Vero cells were passaged in medium 199 supplemented with 5 % bovine serum. The virus strains used were HSV-1(17) (Brown et al., 1973) , HSV-1(17)(dUTPase\LAT) and HSV-1(17) (dUTPase\gC). Construction of the latter two strains has been described elsewhere (provided by E. Wagner, University of California, Irvine, Calif., USA) (Huang et al., 1993 (Huang et al., , 1994 . HSV-1(17)(dUTPase\LAT) contains the β-galactosidase gene under the control of the immediate early promoter of the gene encoding dUTPase in place of both copies of the LAT genes ; HSV-1(17)(dUTPase\gC) has the same construct inserted in place of the gC gene and is gC − . All viruses were propagated on HEp-2 cells and virus stocks had titres of approximately 10* p.f.u.\ml on Vero cells.
Tissue and cell culture preparation of primary chick cells. Fertile White Leghorn eggs (Sharp Sales) were incubated in a humidifying incubator. Cerebral hemispheres of 6-day-old chick embryos (E6) were mechanically dissociated by passing through a 48 µm nylon monofilament screen (Tetko) (Hennig et al., 1993 ; Mangoura & Vernadakis, 1988) . Neuronal cells were resuspended in DMEM supplemented with 10 % foetal calf serum, 100 U\ml penicillin and 0n1 mg\ml streptomycin. Cell suspensions were either divided into aliquots that were infected immediately with HSV-1 or plated on poly -lysine-treated dishes and allowed to remain in culture at 37 mC and 10 % CO # for 2 or more days before infecting with virus (cultures consist of 98 % neurons) (Hennig et al., 1993 Mangoura & Vernadakis, 1988) . Prior to infection, neurons in culture continued to undergo morphological differentiation including migration and aggregation Mangoura & Vernadakis, 1988) .
Astroglial cultures were prepared according to the method of Sakellaridis et al. (1984) . Monolayer glial cultures were established by mechanical dissociation, as previously described, from cerebral hemispheres of 14-day-old chick embryos (Sakellaridis et al., 1984 (Sakellaridis et al., , 1986 . Cells were maintained at 37 mC and the medium (DMEM with 20 % foetal calf serum) was replenished every third day. Astrocytes were infected with virus when 80 % of cells in culture immunostained positively for glial fibrillary acidic protein (GFAP, Sigma), typically at 14 days in culture.
For primary chick fibroblast cells, skins from the E6 truncal region were washed several times with HBSS buffer (Life Technologies) and dissociated in 0n5 % trypsin as modified from an assay previously described (Pirok et al., 1997) . Cells were then resuspended in DMEM supplemented with 10 % foetal calf serum, 100 U\ml penicillin and 0n1 mg\ml streptomycin, counted and immediately infected with HSV-1.
Purification and quantification of virus. Virions were radiolabelled with [$H]thymidine and purified from HEp-2 cells as previously FFA described (Cassai et al., 1975 ; Herold et al., 1991) . For purified virion preparations, titres were determined by plaque assays on both Vero and HEp-2 cells. Virions were quantified by measuring the relative amounts of the VP5 (major capsid) band by optical densitometry as previously described Herold et al., 1994 ; Tal-Singer et al., 1995) and by using a protein dye binding assay from Bio-Rad. Both methods yielded comparable results. For virus binding studies, just prior to use, purified virus was diluted 1 : 5 (v\v) in PBS (10 mM Na # HPO4, 1n5 mM KH # PO % , 140 mM NaCl, 2n5 mM KCl, 0n5 mM MgCl # , 1 mM CaCl # ) and centrifuged at 18 000 g for 1 h in order to concentrate the virus and remove most of the dextran. The virus pellet was then resuspended in PBS. Infectivity titres were determined for the resuspended virus pellets on HEp-2 cells. Infectious virus was quantified using a blue plaque immunoassay as described below (Herold et al., 1994 ; Holland et al., 1983) .
Quantification of β-galactosidase expression from infected neuronal and fibroblast cells. Neuronal cultures, prepared on poly -lysine-treated dishes as described above, were exposed to virus at an m.o.i. of 10 p.f.u. per cell (based on titre of virus stock on HEp-2 cells) at 37 mC for 4-5 h. The virus inoculum was removed and cells were washed with PBS, fixed with 0n5 % glutaraldehyde and treated with a cell membrane permeabilizing solution (0n02 % NP40, 0n01 % deoxycholic acid and 2 mM MgCl # ). β-Galactosidase activity was assessed by X-Gal overlay (0n5 mg\ml X-Gal dissolved in ferric cyanide solution). Cells were examined by light microscopy (Nikon Light Scope). In order to quantify the amount of β-galactosidase activity, aliquots of freshly dissociated neuronal cells or fibroblasts were prepared as described above and infected in duplicate with serial 10-fold dilutions of virus (1-100 p.f.u. per cell based on HEp-2 titre). The number of cells in each sample was based on the average of duplicate readings obtained from a Coulter counter (Coulter Counter Model ZM System). The virus-cell suspensions were rocked on a three-dimensional rotator at 37 mC for 4-5 h. The infected cell preparations were centrifuged at 800 g for 20 min and the supernatant containing the unbound virus inoculum was discarded. Pellets were washed in PBS and then resuspended in 1 ml 0n1 % NP40 in PBS. To quantify β-galactosidase activity (reflecting virus entry), aliquots of resuspended samples were added to microtitration plates in triplicate and o-nitrophenyl β--galactopyranoside solution (ONPG) was added to a final concentration of 4 mg\ml in 0n1 % NP40. Plates were incubated for 1 h at 37 mC and absorbance (410 nm) of the product was determined using a Dynatech MR 600 microplate reader.
Binding of purified virus to primary cells.
Binding studies were performed at 4 mC, modified from previously described methods (Herold et al., 1991) . Serial dilutions of purified [$H]thymidine-labelled virus of known relative concentration (based on VP5 units) and titre (HEp-2 titre) were added to primary neuronal cell suspensions for 5 h at 4 mC in duplicate. At the end of the adsorption period, the unbound virus was removed by centrifugation of the cell suspension for 5 min at 800 g. Cells with bound virus were washed and centrifuged three times before resuspending the pellet in PBS-ABC buffer (PBS supplemented with 9 µM CaCl # and 5 µM 0n5 MgCl # ). Cell-bound radioactivity was then quantified by scintillation counting.
Virus plaque assays. Plaque assays were performed in duplicate as previously described (Herold et al., 1991) . HEp-2 or Vero cells in 25 cm# flasks were inoculated with virus in PBS-ABC. After a 2 h adsorption period at 37 mC, the virus inoculum was removed and the cells were overlaid with medium 199 supplemented with 1 % foetal bovine serum and 0n1 % pooled human gamma globulin. Virus plaques were counted after 2 days of incubation. Vero cells were fixed and stained with Giemsa to visualize plaques. To visualize HEp-2 cells, an immunoassay (blue plaque assay) with monoclonal antibody II-105 (anti-gB, gift of P. Spear, Northwestern University Medical School, Chicago, USA) was performed as previously described (Herold et al., 1991 ; Holland et al., 1983) .
Inhibitory agents and enzymatic treatment of cells. The syntheses and structural characterization of all the modified heparin compounds (obtained from Glycomed) have previously been described (Herold et al., 1996 . Lyophilized compounds were resuspended in PBS, aliquoted and stored at k20 mC. Heparin (Sigma), chondroitin sulfate A (CS, Sigma) and dermatan sulfate (DS, Sigma) were dissolved in PBS at the concentrations indicated immediately prior to use or stored at k20 mC . The molecular masses of starting polysaccharides were in the comparable range of 14 000 Da. Heparitinase (Seikagaku) and chondroitin ABC lyase (Seikagaku) enzymes were diluted in PBS with 0n1 % bovine serum albumin immediately before adding to cells. (Activities of both enzymes were assessed in parallel with the appropriate substrates.) In the experiments designed to test the effects of enzymatic treatment of cells, cells were exposed to the enzymes for 2 h at 37 mC and then inoculated with virus and, after 4-5 h, assayed for β-galactosidase activity. These results were compared to results obtained from neuronal suspensions containing only cells, cells and enzyme without virus inoculum, and virus inoculum without pretreatment with enzyme.
Results

Identifying HSV-1-susceptible embryonic chick neural cell populations
To identify the primary neural cells susceptible to HSV-1 infection, relatively pure neuronal cultures from E6 cerebral hemispheres (CH) and astroglial cultures from 14-day-old embryonic chick CH were prepared, as described in Methods, and inoculated with various concentrations of HSV-1(17)-(dUTPase\LAT). Infected cells were identified by staining with X-Gal and examining the cells by light microscopy. Mockinfected neuronal aggregates stained with a neurofilament antibody demonstrated that the cells in culture reflect almost entirely neurons (Fig. 1 a) . Blue staining of neuronal aggregates (E6 in culture for 2 days) exposed to virus at an m.o.i. of 1 p.f.u. per cell (Fig. 1 c) contrasted with mock-infected neuronal aggregates (Fig. 1 b) . Similar results were obtained on relatively pure cultures of astrocytes identified by immunostaining with GFAP antibody (data not shown). Thus, both primary neurons and astrocytes in culture are susceptible to HSV-1 infection.
HS is a receptor for entry of HSV-1 into primary neuronal cells
Two independent approaches were adapted to determine if HS (or another GAG) might serve as a receptor for HSV-1 binding to neurons. First, the ability of heparin (an analogue of HS), CS or DS to competitively inhibit entry of virions into chick primary neurons or fibroblasts was determined by measuring β-galactosidase activity after incubating neurons at 37 mC for 5 h with virus in the presence or absence of increasing concentrations of GAGs. The GAGs were added to the virus inoculum immediately prior to infecting dissociated neuronal or fibroblast cells. Heparin inhibited β-galactosidase FFB L. C. Immergluck and others L. C. Immergluck and others activity in primary neuronal cells ( Fig. 2 a) ; this pattern of competitive inhibition was not evident with CS or DS. Using identical assay conditions, the concentration of heparin required to inhibit 50 % of β-galactosidase activity (IC &! ) was " 10 times greater on neuronal cells (" 30 µg\ml) than fibroblast cells (2-3 µg\ml) (Fig. 2 b) . As has previously been described using epithelial or fibroblast cell lines, DS inhibited virus entry into primary chick fibroblast cells, but only at concentrations "100-fold higher than heparin (Banfield et al., 1995 ; WuDunn & Spear, 1989) .
As a second approach to test whether HS moieties located on the neuronal cell surface are involved in virus entry, neuronal cells were exposed to two different enzymes capable of digesting cell surface GAGs. Heparitinase has selectivity for linkages present in HS, whereas chondroitin ABC lyase specifically cleaves glycosidic linkages present in CS and DS.
Treatment of primary neuronal cells with various doses of heparitinase before virus adsorption resulted in a reduction in the number of infected primary embryonic neuronal cells (Fig.  3) . In contrast, virus entry into neurons treated with chondroitin ABC lyase was indistinguishable from untreated cells (Fig. 3) . Similar results were obtained for epithelial cells (data not shown) (Herold et al., 1994) . Taken together, these results suggest that HS plays a role in mediating entry of HSV-1 into primary neuronal cells.
To assess whether the inhibitory effect of heparin on virus entry reflects competition between heparin and cell surface HS for initial attachment to virus ligand, binding assays were performed (Herold et al., 1991) . To quantify binding of virus to cells without the complication of penetration and possible turnover of cell receptors for virus, the binding studies were conducted at 4 mC. Pilot experiments were performed to determine the time required for binding to reach equilibrium using primary neurons in suspension. Cells were exposed to purified [$H]thymidine-labelled virus (m.o.i. of 10) for different times. At various times after inoculation, the unbound virus was removed, cells were washed thoroughly, and scintillation fluid was added for quantification of bound radioactivity. The results showed that 5-6 h was required for the binding reaction to approach equilibrium (data not shown), as has previously been observed for HEp-2 or Vero cells grown in monolayers (Herold et al., 1991) . All subsequent binding studies were conducted for 5-6 h. Fig. 4 shows the results of binding experiments conducted on primary neuronal cells in the presence or absence of increasing concentrations of heparin. Heparin inhibited virus binding, but to a lesser extent than observed for virus entry in the β-galactosidase assay experiments. For example, at concentrations as high as 1000 µg\ml, soluble heparin inhibited approximately 50 % of the virions bound per cell ; but almost 75 % of virus entry was inhibited at a concentration of 100 µg\ml. These findings differ from results previously obtained for epithelial cells grown in monolayer in which the inhibitory effects of heparin on binding at 4 mC paralleled the inhibitory effect of heparin on virus infection as measured by plaque formation (Herold et al., 1991) .
Effect of modified heparin compounds on infectivity of HSV
To determine whether the specific features of HS important for mediating virus entry into neurons were similar to those previously described for epithelial cells (Herold et al., 1996 , the effects of modified heparin compounds on virus entry were assessed. These studies are based on the notion that modified heparin compounds that structurally resemble the cell surface virus receptor will competitively inhibit virus entry, whereas modified heparin compounds that no longer structurally resemble the cell surface receptor will not. Virus was mixed with heparin or modified heparin at various concentrations immediately prior to inoculating neurons in suspension for a β-galactosidase assay. N-Desulfation, but not N-deacetylation, abolished the antiviral activity for HSV-1 entry into neuronal cells, suggesting that it is the negatively charged Nsulfated regions of heparin that are involved in virus-neuronal cell interactions (Fig. 5 a) . In general, the N-sulfated saccharide regions tend to contain more iduronic acid units and carry Osulfate groups (Kjellen & Lindhal, 1991 ; Lindahl & Kjellen, 1987) . To compare the importance of O-sulfation, the effects of 6-O-desulfated and 2,3-O-desulfated heparin on virus entry were assessed. 2,3-O-Desulfated heparin had no inhibitory effect on HSV-1 entry into neurons at the highest concentration tested, whereas at a concentration of 1000 µg\ml (27 times that of unmodified heparin), 6-O-desulfated heparin inhibited 50 % of virus entry into neurons. Carboxyl groups also contribute to the negative charge characteristic of heparin and HS and presumably to the conformation of the polysaccharides. The effects of carboxyl-reduced and aminomethylsulfonate (AMS) heparin (replacement of the carboxyl group with an AMS group) on neuronal cell entry were also compared (Fig. 5 b) HSV-1(17) 1n5 5 n 0 i 10) 3n3i10) HSV-1(17)(dUTPase\LAT) 3n3 1 n 5 i 10* 4n5i10) HSV-1(17)(dUTPase\gC) 1n0 5 n 0 i 10( 5n0i10( charged side chain, an AMS group, restored the antiviral effect for both neuronal and epithelial cells (Herold et al., 1996) .
Role of gC in virus entry
Previous studies have shown that gC, a known heparinbinding viral glycoprotein, plays a predominant role in binding of HSV-1 to epithelial cell surfaces (Campadelli-Fiume et al., 1990 ; Herold et al., 1991 ; Svennerholm et al., 1991) . To determine the contribution of gC in HSV-1 entry into neuronal cells, we compared specific binding activity and virus entry as measured by β-galactosidase for gC + and gC − strains. Because the specific infectivity on epithelial cell lines for gC-deletion viruses on an HSV-1(17) background has not been previously reported, we first compared the specific infectivities (p.f.u. per particle) of HSV-1(17), HSV-1(17)(dUTPase\LAT) and HSV-1(17)(dUTPase\gC) on HEp-2 cells (Table 1) . Purified preparations of each virus strain were analysed with respect to titre of infectious units and virion concentration as measured by quantification of relative numbers of virions by comparison of the amounts of VP5 (major capsid protein). As shown in Table 1 , the specific infectivity of HSV-1(17) and HSV-1(17)(dUTPase\LAT) were similar, suggesting that insertion of the reporter construct (and deletion of LAT) did not affect virus infectivity. In contrast, deletion of gC resulted in a tenfold lower specific infectivity compared to either gC + strains, HSV-1(17) and HSV-1(17)(dUTPase\LAT) (P 0n02). This result is consistent with results obtained for gC-deleted viruses on a KOS background Herold et al., 1991 Herold et al., , 1994 , suggesting that gC on both KOS and 17 backgrounds plays a similar role in virus infection on epithelial cell lines. Having demonstrated that the specific infectivities for HSV-1(17) and HSV-1(17)(dUTPase\LAT) were comparable, all subsequent studies were conducted comparing HSV-1(17)-(dUTPase\LAT) as the gC + virus and HSV-1(17)-(dUTPase\gC) as the gC − virus.
Virus entry was compared for the gC + and gC − viruses on E6 neurons and E6 fibroblasts (and HEp-2 as control) as shown ]thymidine-labelled virions of known particle concentration were added to E6 neurons in cell suspension. Binding was carried out for 5 h at 4 mC. After washing away unbound virus, cells were solubilized and transferred to scintillation vials for the quantification of cellbound radioactivity. The concentrations of added virions were determined by densitometry of a Coomassie blue-stained SDS-PAGE gel and are expressed as relative VP5 units and ranged from an input of 1-150 p.f.u. per cell based on HEp-2 titre obtained at the same time. The ratio of radioactivity to particle number for both the gC + and gC − viruses was comparable and thus the results for bound virions are shown as c.p.m. bound. Each point is the average of duplicate determinations and the error bars represent the range of values obtained. Similar results were obtained in three independent experiments conducted.
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in Fig. 6 . Cells grown in suspension were inoculated with purified virus at increasing m.o.i. for 5 h and then quantified for β-galactosidase activity. The virus inoculum was determined based on the m.o.i. on HEp-2 cells and thus represents approximately 10 times more gC − virus particles compared to gC + virus particles. Normalizing the virus input by m.o.i. resulted in no impairment in β-galactosidase activity for gC − viruses compared to gC + viruses on HEp-2 cells (Fig. 6 a) . In contrast, the gC − virus showed a markedly reduced amount of β-galactosidase activity on primary neurons compared to the gC + virus (Fig. 6 b) . Even at an m.o.i. of 100, the β-galactosidase activity was minimal, suggesting an impairment in virus entry. Relative to results obtained for chick neurons, gC − virus expressed much more β-galactosidase activity in chick fibroblasts (Fig. 6 c) . There was no detectable difference between the gC + and gC − viruses at an m.o.i. of 1 or 10 and the virus input required to achieve an absorbance of 0n5 was comparable for both the gC + and gC − viruses on E6 fibroblasts and HEp-2 cell line. The gC + virus did show increased β-galactosidase activity compared to the gC − virus at an m.o.i. of 100, but for both virus strains the absorbance readings were 1n0. These results suggest that the decreased expression of β-galactosidase activity for the gC − virus in neurons more likely reflects differences in cell type and not species of origin.
To determine if the inability of the gC − virus to express β-galactosidase in neurons reflects an even greater impairment in virus binding than has been observed for epithelial cell lines (HEp-2 and Vero cells) (Herold et al., 1994 (Herold et al., , 1991 , binding studies were conducted. In contrast to results obtained on HEp-2 cells in which the gC − virus showed the expected impairment in specific binding activity relative to the gC + virus (data not shown), there was no similar impairment in the binding pattern for the gC − virus in the number of virions bound to primary neurons (concentration of virus input ranged from 1 to 150 p.f.u. per cell based on HEp-2 titre) (Fig. 7) . These results suggest that not only does an impairment in specific binding activity fail to explain the decreased β-galactosidase activity from the gC − virus in neurons, but also that gC may not play as important a role in binding to neurons as it does to epithelial cells. 
Discussion
The results of these studies suggest that there may be differences in the viral and cellular components that mediate entry of HSV-1 into neurons compared to fibroblast cells. For both cell types, HS plays a role as an initial receptor. Soluble heparin (an analogue of cell surface HS), but not CS or DS, inhibited virus binding and immediate early viral gene expression (β-galactosidase activity) on primary neuronal and fibroblast cells. Enzymatic removal of HS, but not CS, reduced the efficiency with which the neuronal cells were infected. The effects of heparatinase were maximal at 0n01 units\ml and further increases in the concentration of enzyme had little additive effects. Presumably this may be due to the high efficiency with which cells are able to generate cell surface HS ; that is, the rate of replacement of cleaved HS moieties is greater than the rate at which heparitinase can cleave HS. Similar results were obtained with HEp-2 cells (Herold et al., 1994 ;  data not shown).
Several differences were observed with respect to the interactions of heparin with primary neuronal cell infection as compared with primary fibroblast cell infection. First, for neuronal cells, the concentration of heparin required to inhibit virus entry differed. For chick fibroblast cells, concentrations as low as 10 µg\ml soluble heparin inhibited " 90 % of virus entry (as measured by β-galactosidase activity) ; in contrast, concentrations of 1000 µg\ml heparin were required to inhibit 80 % of virus entry into primary neurons. Several possibilities could explain this observation. For example, there may be more HS receptors accessible for virus interactions on neurons compared to fibroblast cells. Alternatively, the virus may have a higher affinity for neuronal cell surface HS than for fibroblast cell surface HS and thus higher concentrations of soluble heparin would be required to competitively inhibit the virus-cell interactions. In addition, soluble heparin might not resemble the neuronal cell surface HS receptor(s) as well as it resembles fibroblast cell surface HS virus receptors and thus would be a less efficient competitive inhibitor.
A second difference observed in these studies is that similar concentrations of soluble heparin did not inhibit virus binding to neurons as well as virus entry. In previous studies, using monolayers of epithelial cell lines, the effects of heparin on binding and immediate early gene expression and plaque formation were similar (Herold et al., 1991 ; B. Herold & A. Siston, unpublished data) . However, in these studies, we found that heparin inhibited only about 50 % of virus binding even at concentrations as high as 1000 µg\ml. This discrepancy could reflect the fact that more virus particles bind to a cell surface than actually penetrate. Because the neuronal cells are maintained in suspension, the number of accessible receptors for virus binding may be greater than when cells are grown in a monolayer. Soluble heparin may competitively inhibit only a subset of the virus particles that are bound to cell surface HS, but have little inhibitory effect on other virus particles that bind but never enter. There also may be differences in the effects of heparin at 4 mC and 37 mC on HSV-neuronal cell interactions. It is possible that heparin may inhibit not only the initial binding of virus to neurons measured at 4 mC, but also inhibit subsequent interactions at the cell surface such as secondary binding and penetration (Haywood, 1994 ; Herold et al., 1996) .
Differences were also observed with respect to the effects of chemically modified heparins on virus infection of neuronal cells compared to what has been observed with permanent epithelial cell lines or primary human epithelial cells. For both neuronal and epithelial cells, it is the N-sulfated saccharide sequences, rather than the N-acetylated sequences, that are important for virus-cell interactions. However, in the neuronal cell studies, only N-desulfation and 2,3-O-desulfation abolished the antiviral activity of heparin for virus entry. 6-O-Desulfation lowered the antiviral activity, but significant antiviral activity was retained at higher concentrations. These results with Odesulfated compounds are reversed for several different epithelial cells (HEp-2, Vero and primary human cervical cells) in that for the epithelial cells, 2,3-O-desulfated heparin inhibited better than 6-O-desulfated heparin (Herold et al., 1996 ; B. Herold & A. Siston, unpublished data) . These results suggest that the relative contribution of O-sulfations within heparin differs for neuronal and epithelial cells and that there may be either species-specific or tissue-specific differences in the structural sequences within HS to which virus preferentially binds on neuronal and epithelial cells.
Not only were differences observed with respect to the ability of heparin and modified heparins to inhibit neuronal cell infection compared to epithelial cell infection, but there were also differences observed with respect to the role of viral gC on the two cell types. Although gC is considered a ' non-essential ' glycoprotein because it is dispensable for virus replication in cell culture, it has been shown to play an important role in the binding of HSV-1 to epithelial cell surface HS (CampadelliFiume et al., 1990 ; Herold et al., 1991 ; Svennerholm et al., 1991) . This conclusion is based on the observations that deletion of the gene for HSV-1 gC results in mutants that are impaired in ability to bind to cells and have a reduced specific infectivity (Herold et al., 1991) . Most of these studies have been conducted using permanent epithelial cell lines and gC mutants from an HSV-1(KOS) background. We also found similar results for an HSV-1(17) gC-deletion virus on HEp-2 cells. As expected, the gC − virus had a reduced specific binding activity and specific infectivity compared to the parental wildtype virus or a gC + virus with the same reporter construct. However, results obtained for neuronal cells were quite different. First, we found that there was no impairment in the ability of the gC − virus to bind to neuronal cells (virion particles bound per cell). However, there was a marked reduction in the ability of the gC − virus to infect neuronal cells and express an immediate early reporter gene, β-galactosidase. These results could not be explained by species of origin of the FFG primary neuronal cells since primary chick fibroblasts yielded results similar to those obtained on the HEp-2 cell line. Rather, the results obtained for neurons suggest that gC does not play the same role in initial binding to neurons as it does to fibroblasts or epithelial cells, but does play a key role in entry at a step beyond the initial binding of virus to the cell surface. Similar results were obtained in studies comparing the entry of gC + and gC − virus into rat dorsal root ganglia (J. Kiser, L. R. Stanberry & B. Herold, unpublished data) . Taken together, these results suggest that gC may be an important determinant of neuronal cell infection.
The notion that gC might play a role in neuronal cell infection is not without precedent. For example, the gC homologue in the related animal herpesvirus, pseudorabies virus (PrV), has been shown to play an accessory role in neurovirulence (Kritas et al., 1994 ; Mettenleiter et al., 1988) . Using a similar chick model, Mettenleiter et al. (1988) found that single mutations in gC, gE or gI of PrV had little effect on virulence for day-old chickens inoculated intracerebrally. However, mutants defective in both gC and gE or both gC and gI were avirulent for chickens, despite their ability to grow in cell culture on chick embryo fibroblasts. These studies suggest that gC, in conjunction with gE or gI, plays a role in PrV neurovirulence. Similar results with respect to PrV gC have been obtained in studies of the rat visual system (Babic et al., 1996 ; Card & Enquist, 1995 ; Card et al., 1992) . Taken together these studies suggest an accessory role for gC with respect to neurovirulence in both the chick and rat animal models of PrV. Clearly, further studies using different virus strains and multiple animal models are necessary to understand the contribution of gC and other viral glycoproteins to neuronal cell infection. Requirements for virus binding and entry may differ between epithelial and neuronal cells, among different populations of neuronal cells, and among different species.
This study describes some of the viral and cellular requirements for HSV-1 infection of primary chick neuronal cells in culture. Primary neurons in culture reflect an array of cells characteristic of an in vivo environment which is not afforded by cell lines. The mechanisms for attachment and internalization of virions by nerve cells can be explored in such a system. Results obtained in these studies suggest that there are differences in the requirements for virus entry into neurons compared to epithelial and fibroblast cells. Together, these observations have laid the foundation for further exploring the nature of virus-neuron interactions and isolating neuronal receptor(s) important in HSV-1 infections. Future studies designed to determine the role of viral glycoproteins in neuronal cell infection will be important not only for understanding neurovirulence and pathogenicity of HSV, but also for the development of HSV-1 vectors for neuronal cell targeted gene therapy.
